Curis, Inc.
FUSED AMINO PYRIDINE AS HSP90 INHIBITORS
Last updated:
Abstract:
The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of HSP90 related diseases and disorders such as cancer, an autoimmune disease, or a neurodegenerative disease.
Status:
Application
Type:
Utility
Filling date:
29 Oct 2020
Issue date:
23 Sep 2021